|
⚲
|
| Keyboard |
| Abrahmsen Lars B
✚
|
|
|---|---|
| CIK # | 0001789039 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001789039] | |
| 4 | [0001789039] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Aprea Therapeutics Inc | |
| Abrahmsen Lars B |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aprea Therapeutics Inc APRE
Stock Option (right to Buy) · derivative
|
2022-03-10 | Grant | 100,000 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2022-03-10 | Grant | 24,700 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2021-10-01 | Sell | 50,000 | $4.89 | 244,500 |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2021-10-01 | Option exercise | 50,000 | $0.92 | 46,000 |
|
Aprea Therapeutics Inc APRE
Stock Option (right to Buy) · derivative
|
2021-10-01 | Option exercise | 50,000 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2021-09-20 | Option exercise | 25,000 | $0.92 | 23,000 |
|
Aprea Therapeutics Inc APRE
Stock Option (right to Buy) · derivative
|
2021-09-20 | Option exercise | 25,000 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2021-09-20 | Sell | 25,000 | $4.97 | 124,250 |
|
Aprea Therapeutics Inc APRE
Stock Option (right to Buy) · derivative
|
2021-02-25 | Grant | 82,000 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2021-02-25 | Grant | 19,000 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Stock Option (right to Buy) · derivative
|
2020-03-24 | Grant | 31,600 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Stock Option (right to Buy) · derivative
|
2019-10-07 | Grant | 77,630 | $0.00 |